Tämähän on kuin lääketeollisuuden ja diabeteksen hoitolaitteita valmistavan teollisuuden Kuka Kukin On. Tutkijaporukan sidonnaisuudet:
Lainaa:
DISCLOSURE
T Ichikawa received grants from Abbott Japan Co. Ltd. E Ushigome received grant support from the Japanese Study Group for Physiology and Management of Blood Pressure, the Astellas Foundation for Research on Metabolic Disorders (grant number: 4024) and Mishima Kaiun Memorial Foundation. M Hamaguchi received grants from AstraZeneca K.K., Ono Pharma Co. Ltd., Kowa Pharma Co. Ltd. Fukui M received grants from Ono Pharma Co. Ltd., Oishi Kenko inc., Yamada Bee Farm, Nippon Boehringer Ingelheim Co. Ltd., Kissei Pharma Co. Ltd., Mitsubishi Tanabe Pharma Corp., Daiichi Sankyo Co. Ltd., Sanofi K.K., Takeda Pharma Co. Ltd., Astellas Pharma Inc., MSD K.K., Kyowa Kirin Co., Ltd., Sumitomo Dainippon Pharma Co., Ltd., Kowa Pharma Co. Ltd., Novo Nordisk Pharma Ltd., Sanwa Kagagu Kenkyusho CO., Ltd., Eli Lilly, Japan, K.K., Taisho Pharma Co., Ltd., Terumo Corp., Tejin Pharma Ltd., Nippon Chemiphar Co., Ltd., Abbott Japan Co. Ltd., and Johnson & Johnson K.K. Medical Co. and TERUMO CORPORATION. All authors’ grants were outside the submitted work. The other authors declare no conflict of interest.